Lion Point Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,350	Closed	-$1.15M	–	27
2024 Q2	$1.15M	Buy	8,350 +850	+11%	+$117K	2.1%	10
2024 Q1	$1.03M	Buy	+7,500	New	+$1.03M	0.58%	12